Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Douglas S. Krakower, M.D.

Co-Author

This page shows the publications co-authored by Douglas Krakower and Kenneth Mayer.
Connection Strength

20.888
  1. Routine screening for hepatitis C in MSM on HIV PrEP. Nat Rev Urol. 2019 May; 16(5):272-274.
    View in: PubMed
    Score: 0.835
  2. Patterns and clinical consequences of discontinuing HIV preexposure prophylaxis during primary care. J Int AIDS Soc. 2019 02; 22(2):e25250.
    View in: PubMed
    Score: 0.821
  3. Evolving Models and Ongoing Challenges for HIV Preexposure Prophylaxis Implementation in the United States. . 2018 02 01; 77(2):119-127.
    View in: PubMed
    Score: 0.766
  4. Top Questions in ID: Pre-exposure Prophylaxis for HIV. Open Forum Infect Dis. 2017; 4(4):ofx185.
    View in: PubMed
    Score: 0.743
  5. Differing Experiences with Pre-Exposure Prophylaxis in Boston Among Lesbian, Gay, Bisexual, and Transgender Specialists and Generalists in Primary Care: Implications for Scale-Up. AIDS Patient Care STDS. 2017 07; 31(7):297-304.
    View in: PubMed
    Score: 0.731
  6. Primary care clinicians' experiences prescribing HIV pre-exposure prophylaxis at a specialized community health centre in Boston: lessons from early adopters. J Int AIDS Soc. 2016; 19(1):21165.
    View in: PubMed
    Score: 0.700
  7. Editorial Commentary: Can We Afford to Control the HIV Epidemic With Antiretrovirals? Can We Afford Not to Do So? Clin Infect Dis. 2016 12 01; 63(11):1505-1507.
    View in: PubMed
    Score: 0.693
  8. Antiretrovirals for HIV Treatment and Prevention: The Challenges of Success. JAMA. 2016 Jul 12; 316(2):151-3.
    View in: PubMed
    Score: 0.688
  9. Renal Function and Tenofovir Disoproxil Fumarate for Preexposure Prophylaxis: How Safe Is Safe Enough? J Infect Dis. 2016 10 01; 214(7):983-5.
    View in: PubMed
    Score: 0.678
  10. The role of healthcare providers in the roll out of preexposure prophylaxis. Curr Opin HIV AIDS. 2016 Jan; 11(1):41-8.
    View in: PubMed
    Score: 0.663
  11. Infection in 2015: HIV protection with PrEP - implications for controlling other STIs. Nat Rev Urol. 2016 Feb; 13(2):72-4.
    View in: PubMed
    Score: 0.659
  12. Diffusion of Newer HIV Prevention Innovations: Variable Practices of Frontline Infectious Diseases Physicians. Clin Infect Dis. 2016 Jan 01; 62(1):99-105.
    View in: PubMed
    Score: 0.650
  13. Editorial Commentary: Scaling Up Antiretroviral Preexposure Prophylaxis: Moving From Trials to Implementation. Clin Infect Dis. 2015 Nov 15; 61(10):1598-600.
    View in: PubMed
    Score: 0.645
  14. Knowledge, Beliefs and Practices Regarding Antiretroviral Medications for HIV Prevention: Results from a Survey of Healthcare Providers in New England. PLoS One. 2015; 10(7):e0132398.
    View in: PubMed
    Score: 0.641
  15. Editorial commentary: uncoupling epidemiological synergy: new opportunities for HIV prevention for men who have sex with men. Clin Infect Dis. 2015 Jul 15; 61(2):288-90.
    View in: PubMed
    Score: 0.631
  16. Antiretrovirals for primary HIV prevention: the current status of pre- and post-exposure prophylaxis. Curr HIV/AIDS Rep. 2015 Mar; 12(1):127-38.
    View in: PubMed
    Score: 0.626
  17. Pre-exposure prophylaxis to prevent HIV infection: current status, future opportunities and challenges. Drugs. 2015 Feb; 75(3):243-51.
    View in: PubMed
    Score: 0.622
  18. HIV providers' perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study. AIDS Behav. 2014 Sep; 18(9):1712-21.
    View in: PubMed
    Score: 0.604
  19. Engaging healthcare providers to implement HIV pre-exposure prophylaxis. Curr Opin HIV AIDS. 2012 Nov; 7(6):593-9.
    View in: PubMed
    Score: 0.532
  20. What primary care providers need to know about preexposure prophylaxis for HIV prevention: a narrative review. Ann Intern Med. 2012 Oct 02; 157(7):490-7.
    View in: PubMed
    Score: 0.529
  21. Limited Awareness and Low Immediate Uptake of Pre-Exposure Prophylaxis among Men Who Have Sex with Men Using an Internet Social Networking Site. PLoS One. 2012; 7(3):e33119.
    View in: PubMed
    Score: 0.511
  22. Antiretroviral medication and HIV prevention: new steps forward and new questions. Ann Intern Med. 2012 Feb 21; 156(4):312-4.
    View in: PubMed
    Score: 0.504
  23. Promising prevention approaches: tenofovir gel and prophylactic use of antiretroviral medications. Curr HIV/AIDS Rep. 2011 Dec; 8(4):241-8.
    View in: PubMed
    Score: 0.499
  24. HIV Preexposure Prophylaxis and Sexual Satisfaction Among Men Who Have Sex With Men. Sex Transm Dis. 2021 10 01; 48(10):e135-e137.
    View in: PubMed
    Score: 0.247
  25. Brief Report: "I Didn't Really Have a Primary Care Provider Until I Got PrEP": Patients' Perspectives on HIV Preexposure Prophylaxis as a Gateway to Health Care. J Acquir Immune Defic Syndr. 2021 09 01; 88(1):31-35.
    View in: PubMed
    Score: 0.245
  26. Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide for Human Immunodeficiency Virus Preexposure Prophylaxis at a Boston Community Health Center. Open Forum Infect Dis. 2021 Aug; 8(8):ofab372.
    View in: PubMed
    Score: 0.244
  27. Primary Care Providers' Perspectives on Using Automated HIV Risk Prediction Models to Identify Potential Candidates for Pre-exposure Prophylaxis. AIDS Behav. 2021 Nov; 25(11):3651-3657.
    View in: PubMed
    Score: 0.239
  28. Condom use philosophy and behaviors among young men who have sex with men: Variations among HIV pre-exposure prophylaxis users and nonusers. J Am Assoc Nurse Pract. 2020 Apr 08; 33(7):521-528.
    View in: PubMed
    Score: 0.223
  29. US Guideline Criteria for Human Immunodeficiency Virus Preexposure Prophylaxis: Clinical Considerations and Caveats. Clin Infect Dis. 2019 08 16; 69(5):884-889.
    View in: PubMed
    Score: 0.213
  30. Development and validation of an automated HIV prediction algorithm to identify candidates for pre-exposure prophylaxis: a modelling study. Lancet HIV. 2019 10; 6(10):e696-e704.
    View in: PubMed
    Score: 0.211
  31. A Pre-Exposure Prophylaxis Adherence Intervention (LifeSteps) for Young Men Who Have Sex With Men: Protocol for a Pilot Randomized Controlled Trial. JMIR Res Protoc. 2019 Jan 29; 8(1):e10661.
    View in: PubMed
    Score: 0.205
  32. Marcus et al. Respond. Am J Public Health. 2018 12; 108(12):e27-e28.
    View in: PubMed
    Score: 0.203
  33. HIV Preexposure Prophylaxis as a Gateway to Primary Care. Am J Public Health. 2018 10; 108(10):1418-1420.
    View in: PubMed
    Score: 0.198
  34. Pre-exposure prophylaxis for MSM and transgender persons in early adopting countries. AIDS. 2017 10 23; 31(16):2179-2191.
    View in: PubMed
    Score: 0.188
  35. Integrating HIV Preexposure Prophylaxis (PrEP) Into Routine Preventive Health Care to Avoid Exacerbating Disparities. Am J Public Health. 2017 12; 107(12):1883-1889.
    View in: PubMed
    Score: 0.188
  36. Sociodemographic and Clinical Factors Associated With Increasing Bacterial Sexually Transmitted Infection Diagnoses in Men Who Have Sex With Men Accessing Care at a Boston Community Health Center (2005-2015). Open Forum Infect Dis. 2017; 4(4):ofx214.
    View in: PubMed
    Score: 0.187
  37. Preexposure prophylaxis for men who have sex with men and transgender persons in early adopting countries: a narrative review. AIDS. 2017 Aug 28.
    View in: PubMed
    Score: 0.186
  38. Culturally Competent Sexual Healthcare as a Prerequisite for Obtaining Preexposure Prophylaxis: Findings from a Qualitative Study. LGBT Health. 2017 08; 4(4):310-314.
    View in: PubMed
    Score: 0.182
  39. Pre-Exposure Prophylaxis: A Narrative Review of Provider Behavior and Interventions to Increase PrEP Implementation in Primary Care. J Gen Intern Med. 2017 Feb; 32(2):192-198.
    View in: PubMed
    Score: 0.175
  40. Early Adopters: Correlates of HIV Chemoprophylaxis Use in Recent Online Samples of US Men Who Have Sex with Men. AIDS Behav. 2016 07; 20(7):1489-98.
    View in: PubMed
    Score: 0.172
  41. Seasons of Risk: Anticipated Behavior on Vacation and Interest in Episodic Antiretroviral Pre-exposure Prophylaxis (PrEP) Among a Large National Sample of U.S. Men Who have Sex with Men (MSM). AIDS Behav. 2016 07; 20(7):1400-7.
    View in: PubMed
    Score: 0.172
  42. Antiretroviral Preexposure Prophylaxis: Opportunities and Challenges for Primary Care Physicians. JAMA. 2016 Mar 01; 315(9):867-8.
    View in: PubMed
    Score: 0.168
  43. Sexual Behavior Patterns and PrEP Dosing Preferences in a Large Sample of North American Men Who Have Sex With Men. . 2016 Jan 01; 71(1):94-101.
    View in: PubMed
    Score: 0.166
  44. Antiretroviral pre-exposure prophylaxis implementation in the United States: a work in progress. J Int AIDS Soc. 2015; 18(4 Suppl 3):19980.
    View in: PubMed
    Score: 0.161
  45. The Transition From Postexposure Prophylaxis to Preexposure Prophylaxis: An Emerging Opportunity for Biobehavioral HIV Prevention. Clin Infect Dis. 2015 Jun 01; 60 Suppl 3:S200-4.
    View in: PubMed
    Score: 0.159
  46. State-level structural sexual stigma and HIV prevention in a national online sample of HIV-uninfected MSM in the United States. AIDS. 2015 Apr 24; 29(7):837-45.
    View in: PubMed
    Score: 0.158
  47. Perspectives on HIV prevention among urban black women: a potential role for HIV pre-exposure prophylaxis. AIDS Patient Care STDS. 2014 Dec; 28(12):635-42.
    View in: PubMed
    Score: 0.154
  48. Structural Stigma Affects Access to Pre- and Post-exposure Prophylaxis and HIV Risk among Men Who Have Sex with Men (MSM) in the United States. AIDS Res Hum Retroviruses. 2014 Oct; 30 Suppl 1:A22-3.
    View in: PubMed
    Score: 0.152
  49. Differences in PrEP Knowledge and Use in U.S. MSM Users of a Popular Sexual Networking Site Surveyed in August 2013 and January 2014. AIDS Res Hum Retroviruses. 2014 Oct; 30 Suppl 1:A91-2.
    View in: PubMed
    Score: 0.152
  50. Suboptimal awareness and comprehension of published preexposure prophylaxis efficacy results among physicians in Massachusetts. AIDS Care. 2014; 26(6):684-93.
    View in: PubMed
    Score: 0.142
  51. Evolution of Massachusetts physician attitudes, knowledge, and experience regarding the use of antiretrovirals for HIV prevention. AIDS Patient Care STDS. 2012 Jul; 26(7):395-405.
    View in: PubMed
    Score: 0.130
  52. The Promise of Antiretrovirals for HIV Prevention. Curr Infect Dis Rep. 2012 Apr; 14(2):185-93.
    View in: PubMed
    Score: 0.128
  53. Optimizing Provider Preexposure Prophylaxis (PrEP) Training: A Cross-Sectional Analysis of Recommendations from Providers Across the PrEP Implementation Cascade. AIDS Behav. 2021 Jul 21.
    View in: PubMed
    Score: 0.061
  54. Using electronic health records to identify candidates for human immunodeficiency virus pre-exposure prophylaxis: An application of super learning to risk prediction when the outcome is rare. Stat Med. 2020 10 15; 39(23):3059-3073.
    View in: PubMed
    Score: 0.057
  55. Nondaily Use of HIV Preexposure Prophylaxis in a Large Online Survey of Primarily Men Who Have Sex With Men in the United States. J Acquir Immune Defic Syndr. 2020 06 01; 84(2):182-188.
    View in: PubMed
    Score: 0.056
  56. Considering Stigma in the Provision of HIV Pre-Exposure Prophylaxis: Reflections from Current Prescribers. AIDS Patient Care STDS. 2019 02; 33(2):79-88.
    View in: PubMed
    Score: 0.051
  57. Prevention paradox: Medical students are less inclined to prescribe HIV pre-exposure prophylaxis for patients in highest need. J Int AIDS Soc. 2018 06; 21(6):e25147.
    View in: PubMed
    Score: 0.049
  58. A Closer Look at Racism and Heterosexism in Medical Students' Clinical Decision-Making Related to HIV Pre-Exposure Prophylaxis (PrEP): Implications for PrEP Education. AIDS Behav. 2018 04; 22(4):1122-1138.
    View in: PubMed
    Score: 0.048
  59. "Support Your Client at the Space That They're in": HIV Pre-Exposure Prophylaxis (PrEP) Prescribers' Perspectives on PrEP-Related Risk Compensation. AIDS Patient Care STDS. 2017 Apr; 31(4):196-204.
    View in: PubMed
    Score: 0.045
  60. Sexual Stereotypes Ascribed to Black Men Who Have Sex with Men: An Intersectional Analysis. Arch Sex Behav. 2018 01; 47(1):143-156.
    View in: PubMed
    Score: 0.045
  61. Framing HIV Pre-Exposure Prophylaxis (PrEP) for the General Public: How Inclusive Messaging May Prevent Prejudice from Diminishing Public Support. AIDS Behav. 2016 07; 20(7):1499-513.
    View in: PubMed
    Score: 0.043
  62. Putting PrEP into Practice: Lessons Learned from Early-Adopting U.S. Providers' Firsthand Experiences Providing HIV Pre-Exposure Prophylaxis and Associated Care. PLoS One. 2016; 11(6):e0157324.
    View in: PubMed
    Score: 0.043
  63. Knowledge is Power! Increased Provider Knowledge Scores Regarding Pre-exposure Prophylaxis (PrEP) are Associated with Higher Rates of PrEP Prescription and Future Intent to Prescribe PrEP. AIDS Behav. 2015 May; 19(5):802-10.
    View in: PubMed
    Score: 0.040
  64. Sexual frequency and planning among at-risk men who have sex with men in the United States: implications for event-based intermittent pre-exposure prophylaxis. J Acquir Immune Defic Syndr. 2012 Sep 01; 61(1):112-5.
    View in: PubMed
    Score: 0.033
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.